A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
Clinical trial NCT02708095 · COMPLETED
Trial details
- NCT number
- NCT02708095
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-24
- Primary completion
- 2017-10-12
- Enrollment
- 314
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.